Go to deals
Private Equity | Agriculture | Consumer & Retail

Zamira Australia has raised US$5.4 million to fund Companion Animal’s growth initiatives

Zamira Australia has completed a fundraising to support Companion Animal’s growth initiatives and further strengthen its balance sheet.

Zamira is an Australian animal health brand whose mission is to improve the health and well-being of animals across the world. The company is favorably positioned as a premium brand, with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors. The Companion Animal range is Zamira’s new line of Australian-made premium supplements for pets. Formulated by Australian vets using ethically sourced ingredients, ZamiPet helps support digestive and immune function, maintain vitality, joint health, cognitive function, skin, coat and nails, as well as helping support the reduction of stress, tension and anxiety in dogs.

Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise and continues to support Zamira as they strive to become a leader in pet health and well-being, and a global leader in the supply of animal health products.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Justin  Lewis

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Related deals

CAPSA has been acquired by Acrotec SA
Private Equity | Consumer & Retail

CAPSA has been acquired by Acrotec SA

The private owners of CAPSA – Camille Piquerez SA (CAPSA) have sold the company to Acrotec SA, a portfolio company of Carlyle Group.

Learn more
Lonia has been acquired by Studenac
Private Equity | Consumer & Retail

Lonia has been acquired by Studenac

The private shareholder of Lonia has sold the company to Studenac.

Learn more
Quvadec has acquired Resilux through a cash tender offer and delisting
Private Equity | Other Industries

Quvadec has acquired Resilux through a cash tender offer and delisting

Quvadec has acquired Resilux NV through a cash tender offer and delisting.

Learn more